Financhill
Back

Pharming Group Quote, Financials, Valuation and Earnings

Pharming Group Price Quote

$7.48
-0.28 (-3.61%)
(Updated: November 22, 2024 at 5:55 PM ET)

Pharming Group Key Stats

Sell
42
Pharming Group (PHAR) is a Sell

Day range:
$7.31 - $7.80
52-week range:
$6.65 - $13.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.01
P/B ratio:
2.33%

Volume:
12.6K
Avg. volume:
6.3K
1-year change:
-33.39%
Market cap:
$526.4M
Revenue:
$245.3M
EPS:
$-0.27

How Much Does Pharming Group Make?

Is Pharming Group Growing As A Company?

  • What Is Pharming Group's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.12%
  • What Is Pharming Group's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Pharming Group Stock Price Performance

  • Did Pharming Group Stock Go Up Last Month?
    Pharming Group share price went down by -12.91% last month
  • Did PHAR's Share Price Rise Over The Last Year?
    PHAR share price fell by -33.39% over the past 1 year

What Is Pharming Group 52-Week High & Low?

Pharming Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Pharming Group?

  • How Much Debt Does Pharming Group Have?
    Total long term debt quarterly is $95.4M
  • How Much Cash Does Pharming Group Have?
    Cash and short term investments quarterly total is $171.8M
  • What Is Pharming Group’s Book Value Per Share?
    Book value per share is 3.33

Is Pharming Group Cash Flow Positive?

  • What Is PHAR Cash Flow From Operations?
    Cash flow from operations (TTM) is $451K
  • What Is Pharming Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$33.2M
  • What Is Pharming Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $37.5M

Pharming Group Return On Invested Capital

  • Is Management Doing A Good Job?
    PHAR return on invested capital is -5.33%
  • What Is Pharming Group Return On Assets?
    ROA measures how assets are converting to revenues and is -4.08%
  • What Is PHAR Return On Equity?
    ROE is a measure of profitability and is -8.24%

Pharming Group Earnings Date & Stock Price

Pharming Group Competitors

Pharming Group Dividend Yield

Pharming Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 20%
Revenue: 12.28% -1.51%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 33.50
Upside from Last Price: 331.7%

Major Shareholders

  • How many PHAR shares are owned by institutional investors?
    38.5M PHAR shares are owned by institutional investors
  • How many PHAR shares are owned by insiders?
    0 PHAR shares are owned by insiders